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AN UNSEALED PACKAGE: THE NINTH 
CIRCUIT CREATES A CIRCUIT SPLIT 
WHEN INTERPRETING FDA REGULATIONS 
ON FOOD LABEL NUTRIENT CONTENT 
CLAIMS IN REID v. JOHNSON & JOHNSON 
Abstract: On March 13, 2015, in Reid v. Johnson & Johnson, the U.S. Court of 
Appeals for the Ninth Circuit held that the statement “No Trans Fat” on the label 
of Benecol, a food that contains between 0 and 0.5 grams of trans fat, was not a 
permitted nutrient content claim. The court held that such a statement made on 
the label was false or misleading and was therefore not authorized by Food and 
Drug Administration (“FDA”) regulations. The court came to this conclusion de-
spite the Third Circuit reaching the opposite conclusion in 2013, in Young v. 
Johnson & Johnson, regarding the same statement on the same product. Alt-
hough FDA regulations do not expressly discuss the permissibility of a “No 
Trans Fat” nutrient content claim, the FDA issued two warning letters stating that 
this nutrient content claim is unauthorized. This Comment argues that the con-
flict between the Third and Ninth Circuits demonstrates the need for the FDA to 
revisit regulations pertaining to trans fat nutrient content claims. 
INTRODUCTION 
Targeting high levels of sales, eager food manufacturing companies strive 
to find creative ways to make their products appeal to a large variety of con-
sumers.1 In the past few decades, the American population has become more 
health conscious, and food manufacturers have responded by advertising their 
products as “healthy.”2 At the same time, the Food and Drug Administration 
(“FDA”) has been given more authority to regulate what food manufacturers 
may claim on the labels of their products.3 
                                                                                                                           
 1 See Elizabeth O’Connor Tomlinson, Litigation Concerning Unsubstantiated Health Claims 
Regarding Food and Beverages, 127 AM. JURIS. TRIALS 487, § 1, Westlaw (database updated Feb. 
2016) (stating that some companies in the food industry have responded to consumers’ interest in 
healthier foods by making statements on the labels of food that are “misleading and unsubstantiated”). 
 2 See Diana R.H. Winters, The Magical Thinking of Food Labeling: The NLEA as a Failed Stat-
ute, 89 TUL. L. REV. 815, 816 (2015) (stating that in 1990 consumers were learning more about how 
diet affects health); see also Carmen Filosa, Trans Fat Bans the Next Regulatory Taking?, 29 J. LE-
GAL MED. 99, 102 (2008) (noting that Frito-Lay eliminated trans fat from some products so that it 
would not have to label these products as containing trans fats). 
 3 See Nutrition Labeling and Education Act of 1990, Pub. L. No. 101-535, 104 Stat. 2353 (codi-
fied as amended in scattered sections of 21 U.S.C.). The Nutrition Labeling and Education Act of 
1990 (“NLEA”) gave the Food and Drug Administration (“FDA”) the authority to create regulations 
on nutrient content claims and to require the Nutrition Facts panel. See id. 
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In March 2015, in Reid v. Johnson & Johnson (“Reid II”), the U.S. Court 
of Appeals for the Ninth Circuit considered whether a consumer had a cause of 
action against the manufacturers of Benecol for including an allegedly mis-
leading statement on its label.4 Benecol is a margarine-like spread made from 
partially hydrogenated vegetable oil.5 Benecol’s label contained the statement 
“No Trans Fat,” although Benecol contained between 0 and 0.5 grams of trans 
fat per serving.6 
The Ninth Circuit in Reid II faced the issue of whether the plaintiff-
consumer’s claims were preempted by the FDA’s Nutrition Labeling and Edu-
cation Act (“NLEA”).7 Consumers are barred from challenging the validity of 
a nutrient content claim on the label of a product if the nutrient content claim is 
authorized by the FDA.8 Consequently, the court examined whether the FDA 
had permitted the statement “No Trans Fat” for products that contain less than 
0.5 grams of trans fat per serving.9 Reversing the lower court’s ruling, the 
Ninth Circuit held that the FDA did not authorize such a statement in this con-
text.10 It concluded that the plaintiff-consumer was not preempted from bring-
ing his claims.11 In 2013, the Third Circuit reached the opposite conclusion 
when presented with the same issue for the same product in Young v. Johnson 
& Johnson (“Young II”).12 
This Comment argues that the outcome in the Ninth Circuit’s Reid II, jux-
taposed against the outcome in the Third Circuit’s Young II, demonstrates the 
need for the FDA to revisit its regulations regarding trans fat nutrient content 
                                                                                                                           
 4 See Reid v. Johnson & Johnson (Reid II), 780 F.3d 952, 955 (9th Cir. 2015). Reid brought four 
causes of action: two causes of action under the California Unfair Competition Law, one cause of 
action under the California False Advertising Law, and one cause of action under the Consumer Legal 
Remedies Act. See Reid v. Johnson & Johnson (Reid I), No. 3:11-cv-01310, 2012 WL 4108114, at *2 
(S.D. Cal. Sept. 18, 2012), aff’d in part, rev’d in part, 780 F.3d 952. 
 5 See Reid II, 780 F.3d at 955. 
 6 See id. at 957. Reid also contested the labeling of the statement “No Trans Fatty Acids” on Ben-
ecol’s label. See Reid I, 2012 WL 4108114, at *1. Apart from trans fat claims, Reid challenged the 
inclusion of a statement on Benecol’s label regarding the health benefits of plant stanol esters, an 
ingredient in Benecol, and the statement “Proven to Reduce Cholesterol.” See Reid II, 780 F.3d at 
957. 
 7 See Reid II, 780 F.3d at 952. 
 8 See 21 U.S.C. § 343-1(a) (2012) (stating that a plaintiff cannot challenge any statements on the 
label of food under state law if state law imposes food labeling requirements that conflict with federal 
requirements). 
 9 See Reid II, 780 F.3d at 959, 962–63; see infra notes 69–80 and accompanying text (examining 
the Ninth Circuit’s analysis in Reid II). 
 10 See Reid II, 780 F.3d at 963. 
 11 See id. 
 12 See Young v. Johnson & Johnson (Young II), 525 F. App’x 179, 183 (3d Cir. 2013). In 2013, 
the U.S. Court of Appeals for the Third Circuit, in Young v. Johnson & Johnson (“Young II”), held 
that the nutrient content claim “No Trans Fat” was permitted, even though Benecol contained between 
0 and 0.5 grams of trans fat per serving. See id. 
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claims.13 Part I of this Comment discusses the relevant regulations relating to 
food labeling as well as the factual and procedural history of Reid II and Young 
II.14 Part II explores the circuit split between the Third Circuit and the Ninth 
Circuit.15 Finally, Part III argues that the FDA needs to revisit its regulations 
pertaining to the permissibility of trans fat nutrient content claims in order to 
achieve uniform labeling requirements and to avoid misleading consumers.16 
I. REGULATIONS ON FOOD LABELING AND OTHER COURTS’ 
INTERPRETATIONS OF TRANS FAT REGULATIONS 
In the 1980s, as consumers began to understand that nutrition relates to 
health, food manufacturers increased their usage of unsupported health claims 
on food labels.17 In response, Congress sought to improve food-labeling regu-
lations with the passage of the NLEA in 1990.18 Section A of this Part de-
scribes the current state of food-labeling regulations.19 Section B discusses 
relevant applications of federal food-labeling regulations and reviews the facts 
and procedural posture of Reid II and Young II.20 
A. Restrictions on Nutrient Content Claims on the Packaging of Food 
More than seventy years before Reid and Young, Congress passed the 
Federal Food, Drug, and Cosmetic Act of 1938 (“FDCA”) in order to govern 
the labeling of food.21 In 1990, Congress gave the FDA more authority to en-
force food-labeling standards by enacting the NLEA, which amended the 
FDCA.22 The NLEA provided the FDA with the authority to introduce regula-
                                                                                                                           
 13 See infra notes 81–97 and accompanying text. 
 14 See infra notes 17–59 and accompanying text. 
 15 See infra notes 61–80 and accompanying text. 
 16 See infra notes 81–97 and accompanying text. 
 17 See Winters, supra note 2, at 824–25 (stating that Congress passed the NLEA as a response to 
the increase of consumers who valued nutrition and concerns over food manufacturers’ ability to state 
unsubstantiated health claims). Food manufacturers were able to make such heath claims because 
consumers did not have a developed understanding of nutrition. See id. 
 18 See H.R. REP. NO. 101-538, at 8 (1990), reprinted in 1990 U.S.C.C.A.N. 3336, 3339 (describ-
ing the need for legislation that would allow the FDA to enforce accurate labeling of health claims). 
 19 See infra notes 21–38 and accompanying text. 
 20 See infra notes 39–59 and accompanying text. 
 21 See 21 U.S.C. §§ 341–350l-1 (containing the provisions of the Federal Food, Drug, and Cos-
metic Act (“FDCA”) related to food); see also Emily Marden, Risk and Regulation: U.S. Regulatory 
Policy on Genetically Modified Food and Agriculture, 44 B.C. L. REV. 733, 759 (2003) (providing a 
brief overview of the statutory support for the FDA’s regulations on food labeling). 
 22 See 104 Stat. at 2353 (stating that the purpose of the NLEA was “to prescribe nutrition labeling 
for foods, and for other purposes”). Congress passed the NLEA with the goal of establishing national 
uniform standards in food labeling. See H.R. REP. NO. 101-538, at 7 (noting that Congress desired to 
establish national standards through which “food products disclose the amount of specified nutrients 
in foods. . . . [and] [e]very covered food would have a uniform nutrition label disclosing the amount of 
calories, fat, salt and other nutrients”). 
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tions on nutrient content claims and to require the Nutrition Facts panel on 
food labels.23 
A nutrient content claim is a statement on a food label that “expressly or 
implicitly characterizes” the amount of a nutrient that is required to be dis-
closed separately in the Nutrition Facts panel.24 As a result of the NLEA, ex-
pressed and implied nutrient content claims are permitted only if they are de-
fined in FDA regulations.25 The “General Principles” regulations permit an 
expressed nutrient content claim if it is not “false or misleading in any re-
spect.”26 The “Specific Requirements for Nutrient Content Claims” regulations 
define total fat content claims: statements of “fat free,” “free of fat,” “no fat,” 
and “zero fat” are permitted if the food contains less than 0.5 grams of total fat 
per serving.27 The regulations also contain an equivalent definition for saturat-
ed fat.28 The FDA has not defined a similar claim for trans fat due to unreliable 
studies on the health consequences of trans fat.29 
                                                                                                                           
 23 See 21 U.S.C. § 343 (giving the FDA the authority to create more regulations); H.R. REP. NO. 
101-538, at 7 (stating the purpose of the NLEA). The NLEA also created regulations on health claims. 
See § 3, 104 Stat. at 2357. Health claims are claims that link the product or one of its ingredients to “a 
disease or health-related condition.” See 21 C.F.R. § 101.14(a) (2015). 
 24 See 21 C.F.R. § 101.13(b). Nutrient content claims are categorized as expressed or implied 
claims. See id. An expressed nutrient content claim explicitly states the amount of a nutrient in the 
food, such as the statement “contains 5 grams of sugar.” See id. § 101.13(b)(1). An implied nutrient 
content claim either implies that a certain level of a nutrient exists in the food or explicitly states the 
amount of a nutrient in conjunction with a statement relating to health benefits. See id. § 101.13(b)(2). 
 25 See id. § 101.13(b) (stating that nutrient content claims may only be made if they meet the 
“applicable regulations” of Title 21, chapter I). Nutrient content claims are permitted only if they meet 
the “General Principles” requirements listed in 21 C.F.R. § 101.13, titled “Nutrient Content Claims-
General Principles” and any applicable regulations in Subpart D, titled “Specific Requirements for 
Nutrient Content Claims.” See id. §§ 101.13, 101.54–.69. 
 26 See id. § 101.13(i)(3). In contrast, the regulations permit an implied nutrient content claim 
about the level of a nutrient if it either includes a disclaimer or is consistent with Subpart D of 21 
C.F.R. § 101, titled “Specific Requirements for Nutrient Content Claims.” See id. § 101.13(i)(1)–(2). 
For example, “less than 3g of fat per serving” indicates that this level of fat is healthy, but the state-
ment is also consistent with the definition for total fat nutrient content claims listed in Subpart D. See 
id. § 101.13(i)(1). Subpart D’s “Specific Requirements for Nutrient Content Claims” regulations con-
tain specific requirements for nutrient content claims on fats. See id. § 101.62(b)–(c). 
 27 See id. § 101.62(b)(1) (stating specific requirements for nutrient content claims regarding total 
fat). In addition to containing less than 0.5 grams of total fat per serving, total fat content claims must 
meet other conditions listed in this regulation. Id. § 101.62(b) (stating that terms like “no fat” may be 
used if “the food contains less than 0.5 gram[s] (g) of fat per reference amount customarily consumed 
and per labeled serving” and if other conditions are met). The “Specific Requirements for Nutrient 
Content Claims” regulations, which comprise Subpart D, contain specific requirements for nutrient 
content claims regarding “high,” “more,” “good source,” and “high potency”; “light” or “lite”; the 
calorie content of foods; the sodium content of foods; fat, fatty acid, and cholesterol content of foods; 
butter content; and for implied nutrient content claims. See id. §§ 101.54–.69; see also Winters, supra 
note 2, at 828 (describing regulations for nutrient content claims). 
 28 See 21 C.F.R. § 101.62(c)(1) (stating specific requirements for nutrient content claims regard-
ing saturated fat). 
 29 See Food Labeling: Trans Fatty Acids in Nutrition Labeling, Nutrient Content Claims, and 
Health Claims, 68 Fed. Reg. 41,434, 41,465 (July 11, 2003) (codified at 21 C.F.R. pt. 101). Although 
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The Nutrition Facts panel is a required label on the packaging of food and 
contains nutrition information per serving.30 Any information within the Nutri-
tion Facts panel is not classified as a nutrient content claim and is therefore not 
subject to the nutrient content claim requirements.31 Regulations require that 
fat contents be disclosed within the Nutrition Facts panel.32 For example, the 
amount of total fat, saturated fat, and trans fat must be written as grams per 
serving and, if the serving contains less than five grams, rounded to the nearest 
half-gram increment.33 If the serving contains less than 0.5 grams of total fat, 
saturated fat, or trans fat, the amount must be written as 0g.34 Because different 
regulations apply to statements within the Nutrition Facts panel and to nutrient 
content claims, a statement authorized within the Nutrition Facts panel may or 
may not be authorized as a nutrient content claim.35 
                                                                                                                           
the FDA required grams of trans fat to be included in the Nutrition Facts panel, it chose to not define 
trans fat nutrient content claims until more research became available on the appropriate daily con-
sumption value of trans fat. Id. at 41464–65; see also Food Labeling: Revision of the Nutrition and 
Supplement Facts Labels, 79 Fed. Reg. 11,880, 11,897 (proposed Mar. 3, 2014) (to be codified at 21 
C.F.R. pt. 101) (stating that, as of 2014, scientific information is still not available for the FDA to 
determine a daily reference value for trans fat); Reid II, 780 F.3d at 960 (discussing authorized fat-
related nutrient content claims and noting that the FDA did not define a trans fat nutrient content 
claim). As of the date of publication of this Comment, a daily value for trans fat has not yet been de-
fined. See 21 C.F.R. § 101.9(c)(9). The FDA does, however, recognize the negative health conse-
quences of trans fat. See Food Labeling: Revision of the Nutrition and Supplement Facts Labels, 79 
Fed. Reg. at 11,893 (noting that experts recommend replacing saturated fat and trans fat with healthier 
fats); Tentative Determination Regarding Partially Hydrogenated Oils; Request for Comments and for 
Scientific Data and Information, 78 Fed. Reg. 67,169, 67,169 (Nov. 8, 2013) (stating that the FDA 
“tentatively determined” that partially hydrogenated oils, a large source of artificial trans fat, are not 
safe for consumption). 
 30 See 21 C.F.R. § 101.9(b) (requiring nutrients within the Nutrition Facts panel to be measured 
per serving); id. § 101.9(c) (stating what information the Nutrition Facts panel must contain). FDA 
regulations refer to the Nutrition Facts panel as nutrition labeling. See id. § 101.9; see also Winters, 
supra note 2, at 816 (stating that the NLEA’s objective of disclosing nutrition in the Nutrition Facts 
panel has been accomplished). 
 31 See 21 C.F.R. § 101.13(c); see also Chacanaca v. Quaker Oats Co., 752 F. Supp. 2d 1111, 1114 
(N.D. Cal. 2010) (noting that the statement “0 grams trans fat” within the Nutrition Facts panel of the 
Chewy Bar box is not a nutrient content claim but that the same information stated outside of the 
Nutrition Facts panel is a nutrient content claim). 
 32 See 21 C.F.R. § 101.9(c)(2). 
 33 See id. § 101.9(c)(2)(ii); see, e.g., Reid II, 780 F.3d at 959 (applying regulations for disclosure 
of trans fat in the Nutrition Facts panel to the food product Benecol); Carrea v. Dreyer’s Grand Ice 
Cream, Inc., 475 F. App’x 113, 115 (9th Cir. 2012) (applying regulations for disclosure of trans fat in 
the Nutrition Facts panel to the food product Drumstick); Chacanaca, 752 F. Supp. 2d at 1119 (apply-
ing regulations for disclosure of trans fat in the Nutrition Facts panel to the food product Chewy 
Bars). 
 34 See 21 C.F.R. § 101.9(c)(2)(ii). 
 35 See Reid II, 780 F.3d at 960 (recognizing that the information required in the Nutrition Facts 
panel is not necessarily permitted outside of the panel). 
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 Litigating food labeling requires determining at the outset whether FDA 
regulations authorize the claim.36 The NLEA contains a preemption provision 
that bars any cause of action that arises from state food-labeling requirements 
that are not the same as federal requirements.37 Plaintiffs challenging nutrient 
content claims under state law causes of action cannot bring their claims if 
federal regulations permit the challenged statements.38 
B. Food Labeling Regulations in Practice 
Although the NLEA aimed to establish which nutrient claims can be 
made on the label of a food product, litigation in the area of trans fat reflects 
the ambiguity that remains in FDA regulations of trans fat.39 Two recent cases 
that both addressed the question of trans fat nutrient content claims, Chacana-
ca v. Quaker Oats Co. and Young v. Johnson & Johnson (“Young I”), utilized 
different reasoning to come to the determination that the nutrient content 
claims at issue were authorized by FDA regulations.40 Similarly, in 2012, in 
                                                                                                                           
 36 See Chacanaca, 752 F. Supp. 2d at 1119 (stating that a plaintiff’s claim would be preempted if 
the plaintiff is trying to enforce a requirement that is not the same as FDA regulations). For example, 
if a plaintiff wants to challenge a nutrient content claim as misleading, he or she can only do so if the 
nutrient content claim would be misleading under FDA regulations. See id. 
 37 See 21 U.S.C. § 343-1(a)(5). By eliminating state-imposed food labeling requirements that 
were not identical to federal requirements, Congress pursued its goal of establishing uniform food 
labeling. See H.R. REP. NO. 101-538, at 8. The term “‘not identical to’ . . . means that the State re-
quirement directly or indirectly imposes obligations or contains provisions concerning the composi-
tion or labeling of food” that “[a]re not imposed by or contained in the applicable provision[s].” 21 
C.F.R. § 100.1(c)(4) (2015); see, e.g., CAL. HEALTH & SAFETY CODE § 110100 (West 2012) (stating 
that all federal food regulations shall be the regulations of California); ILL. ADMIN. CODE tit. 77, 
§ 720.40 (2016) (providing regulations on food labeling); N.Y. COMP. CODES R. & REGS. tit. 1, 
§ 259.1 (2016) (adopting specified federal food labeling regulations for fresh produce as regulations 
for New York). For example, in 2006, in Mills v. Giant of Maryland, LLC, the U.S. District Court for 
the District of Columbia held that that the state requirement of including a warning on milk products 
about lactose intolerance exceeded the requirements of the NLEA and was therefore preempted. See 
441 F. Supp. 2d 104, 108 (D.D.C. 2006). 
 38 See Young II, 525 F. App’x at 185 (dismissing the plaintiff’s complaint because his causes of 
action were preempted by the NLEA). 
 39 See, e.g., Walker v. B&G Foods, Inc., No. 3:15-cv-03772, 2016 WL 463253, at *1 (N.D. Cal. 
Feb. 8, 2016) (analyzing whether the FDA authorized the claim “0g Trans Fat”); Guttmann v. Nissin 
Foods (U.S.A.) Co., Inc., No. 3:15-cv-00567, 2015 WL 4309427, at *1 (N.D. Cal. July 15, 2015) 
(same); Peviani v. Hostess Brands, Inc., 750 F. Supp. 2d 1111, 1114 (C.D. Cal. 2010) (analyzing 
whether the FDA authorized the claim “0 Grams of Trans Fat”); Red v. Kroger Co., No. 2:10-cv-
01025, 2010 WL 4262037, at *5 (C.D. Cal. Sept. 2, 2010) (analyzing whether the FDA authorized the 
claim “0g Trans Fat”). Compare Reid II, 780 F.3d at 963 (finding that including the statement “No 
Trans Fat” outside the Nutrition Facts label was misleading and thus not permitted), with Carrea, 475 
F. App’x at 115 (ruling that the nutrient content claim “0g Trans Fat” was not misleading), and Young 
II, 525 F. App’x at 183 (holding that the nutrient content claim “No Trans Fat” was authorized). 
 40 See Young v. Johnson & Johnson (Young I), No. 11-cv-4580, 2012 WL 1372286, at *3 (D. N.J. 
Feb. 27, 2013) (holding that the statement “No Trans Fat” was a permitted nutrient content claim), 
rev’d, 525 F. App’x 179; Chacanaca, 752 F. Supp. 2d at 1121 (holding that the statement “0 grams 
trans fat” was a permitted nutrient content claim). 
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Reid v. Johnson & Johnson (“Reid I”), the U.S. District Court for the Southern 
District of California held that the trans fat nutrient content claim at issue was 
permitted.41 
In 2010, in Chacanaca v. Quaker Oats Co., the U.S. District Court for the 
Northern District of California held that the nutrient content claim “0 grams 
trans fat” on the Chewy Bar label was permitted.42 Chewy Bars contain be-
tween 0 and 0.5 grams of trans fat per serving, and thus, in the Nutrition Facts 
panel, the amount of trans fat must be rounded down to zero.43 The court held 
that the trans fat nutrient content claim was permitted based on supplementary 
information provided by the FDA in its final rule about food labeling and nu-
trient content claims.44 When discussing reference claims, the FDA stated in 
this supplementary information that rounded and unrounded amounts of a nu-
trient are nutritionally the same and that relative claims should state infor-
mation consistently throughout the label.45 From this, the court concluded that 
the statement “0 grams trans fat” was not misleading.46 The statement there-
fore met the FDA’s requirements for an expressed nutrient content claim.47 As 
a result, any claims related to the claim “0 grams trans fat” were preempted.48 
In 2012, in Young I, the U.S. District Court for the District of New Jersey 
determined that the nutrient content claim “No Trans Fat” on the Benecol label 
was similarly permitted.49 The plaintiff alleged that the statement was false and 
misleading because Benecol contains some trans fat.50 The court reached its 
                                                                                                                           
 41 See Reid I, 2012 WL 4108114, at *10–11 (reasoning that the statement “No Trans Fat” was a 
permitted nutrient content claim). 
 42 See Chacanaca, 752 F. Supp. 2d at 1121. 
 43 See id. at 1115–16 (referring to 21 C.F.R. § 101.9(c)(2)(ii) (2010)). The court noted that the 
“General Principles” regulations do not explicitly address if nutrient content claims should state the 
actual amount of the nutrient or if they should match the rounded value within the Nutrition Facts 
panel. Id. at 1120. 
 44 See id. at 1120–21 (quoting 58 Fed. Reg. 44,020, 44,024 (Aug. 18, 1993) (codified at 21 C.F.R. 
pts. 5 & 101)). 
 45 See id. (quoting 58 Fed. Reg. at 44,024). Reference claims compare the amount of a nutrient in 
that product to the amount in another product. See id. at 1120. 
 46 See id. at 1121 (reasoning that if 0 grams of trans fat and an amount between 0 and 0.5 grams 
of trans fat are nutritionally equivalent, the trans fat nutrient content claim cannot be misleading). 
 47 See id. 
 48 See id. If the FDA authorized this statement, by reason of it meeting the requirements of an 
expressed nutrient content claim, the plaintiff cannot challenge this statement under state law due to 
the preemption provision. See 21 U.S.C. § 343-1(a)(5). 
 49 See Young I, 2012 WL 1372286, at *5. The court granted the defendant’s motion to dismiss. 
See id. at *6. 
 50 See id. at *5. The plaintiff also alleged that the following statements used on Benecol’s label 
and in its marketing were misleading due to the presence of trans fat: “Proven to Reduce Cholesterol,” 
“No Trans Fatty Acid,” “1/2 the fat and calories of margarine,” “excellent source of Vitamin E,” “Part 
of a Healthy Lifestyle, ” and “heart healthy alternative to butter.” See id. at *1. Similarly, the plaintiff 
alleged that a claim indicating that plant stanol provided “health benefits” was misleading. See id. The 
plaintiff brought five causes of action against Johnson & Johnson. See id. 
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conclusion by examining FDA regulations that permit an amount of trans fat 
that is less than 0.5 grams per serving to be written as 0 in the Nutrition Facts 
panel.51 It held that because the statement “No Trans Fat” was authorized in 
the Nutrition Facts panel, it was similarly permitted outside the panel as a nu-
trient content claim.52 On appeal, the Third Circuit affirmed the district court’s 
ruling and held that the claim “No Trans Fat” was permitted by the FDA and 
that the plaintiff’s claims were preempted.53 
Additionally, in 2012, the district court in Reid I held that the nutrient 
content claim “No Trans Fat” on the Benecol label was an authorized claim.54 
Similar to the plaintiff in Young, Reid alleged that the statement “No Trans 
Fat” was false because Benecol contains small amounts of trans fat.55 In ruling 
that the nutrient content claim “No Trans Fat” was permitted, the district court 
adopted the Ninth Circuit’s reasoning from a 2012 unreported decision, Carrea 
v. Dreyer’s Grand Ice Cream, Inc.56 Although the nutrient content claim at is-
sue in Carrea was “0g Trans Fat,” the district court in Reid I found that distin-
guishing between the statements “0g Trans Fat” and “No Trans Fat” was “un-
reasonable.”57 On appeal, the Ninth Circuit disagreed with the district court’s 
                                                                                                                           
 51 See id. at *5 (referencing 21 C.F.R. § 101.9(c)(2)(ii)). The court noted that regulations for the 
Nutrition Facts panel state that an amount of trans fat that is expressed as zero in the panel is “insig-
nificant.” See id. (referencing 21 C.F.R. § 101.9(f)). 
 52 See id. 
 53 See Young II, 525 F. App’x 179 at 183 (holding that the FDA authorized the claim “No Trans 
Fat”). 
 54 See Reid I, 2012 WL 4108114, at *10. Reid brought a class action suit against Johnson & John-
son, the manufacturer and seller of Benecol, and McNeil Nutritionals, a wholly owned subsidiary of 
Johnson & Johnson. See id. at *1. 
 55 See id.; see also Young II, 525 F. App’x at 182. Benecol contains between 0 and 0.5 grams of 
trans fat per serving. See Reid I, 2012 WL 4108114, at *1. Reid also alleged that the statement “No 
Trans Fatty Acids” was false. See id. 
 56 See Reid I, 2012 WL 4108114, at *10 (adopting the reasoning from Carrea v. Dreyer’s Grand 
Ice Cream, Inc., which held that a claim of “0g Trans Fat” was authorized by the FDA, and stating 
that the “terms are functionally equivalent”). In an unreported 2012 opinion, Carrea v. Dreyer’s 
Grand Ice Cream, Inc., the Ninth Circuit held that the nutrient content claim “0g Trans Fat” was per-
mitted, even though the food product contained between 0 and 0.5 grams of trans fat per serving. See 
475 F. App’x at 115. The court concluded that the statement was an expressed nutrient content claim 
that was not “false or misleading” and was thus authorized under the “General Principles” regulations. 
See id. (citing 21 C.F.R. § 101.13(i)(3)). The court held that the supplementary information provided 
by the FDA for its final rule on food labeling and nutrient content claims, which stated that relative 
claims should state information consistently throughout the label, did not merely permit but “in-
struct[ed]” that the trans fat nutrient content claim match information contained within the Nutrition 
Facts panel. See id. (referring to 58 Fed. Reg. at 44,024–25). FDA regulations require that less than 
0.5 grams of trans fat per serving be listed in the Nutrition Facts panel as zero grams. See 21 C.F.R. 
§ 101.9(c)(2)(ii)). In 2010, the U.S. District Court for the Northern District of California referred to 
the same language in the same agency final rule, when it stated in Chacanaca v. Quaker Oats Co. that 
the FDA “prefer[red]” consistency between nutrient content claims and information in the Nutrition 
Facts panel. See 752 F. Supp. 2d at 1121 (referring to 58 Fed. Reg. at 44,024). 
 57 See Reid I, 2012 WL 4108114, at *10 (comparing the nutrient content claim in Carrea to that 
in Reid). When discussing standing, the court concluded that because the ingredient list contained 
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conclusion and held that the trans fat claim at issue was not authorized by the 
FDA and that Reid’s claims were not preempted.58 This holding contrasted 
with the Third Circuit’s holding in Young II and created a circuit split on the 
issue of trans fat content claims.59 
II. THE THIRD AND NINTH CIRCUITS’ SPLIT IN INTERPRETING FDA  
REGULATIONS ON TRANS FAT 
The U.S. Courts of Appeals for the Third and Ninth Circuits reached op-
posite decisions when determining if the same nutrient content claim on the 
same product was authorized by the FDA.60 In 2013, in Young v. Johnson & 
Johnson (“Young II”), the U.S. Court of Appeals for the Third Circuit held that 
the nutrient content claim “No Trans Fat” on the Benecol label was an author-
ized claim.61 Because Benecol contains between 0 and 0.5 grams of trans fat 
per serving, the amount of trans fat must be rounded down to 0 in the Nutrition 
Facts panel.62 The court concluded that, based on the Nutrition Facts panel re-
quirements, the nutrient content claims were authorized on a per-serving ba-
sis.63 First, the court noted that FDA regulations consider less than 0.5 grams 
of trans fat to be “an insignificant amount” in the per-serving context.64 Next, 
the court considered that the claims “no fat” and “no saturated fat” were au-
thorized claims based on the grams the product contains per serving, even 
though the claims make no mention of serving size.65 Finally, the court re-
ferred to the supplementary information for the final rule on food labeling and 
                                                                                                                           
partially hydrogenated oils, a reasonable consumer would not assume that the statement “mean[s] that 
Benecol products do not contain any trans fat.” See id. at *4. 
 58 See Reid II, 780 F.3d at 963 (holding that the plaintiff’s claims relating to the trans fat state-
ments were not preempted by the NLEA). 
 59 See id. (holding that the “No Trans Fat” content claim was not authorized by FDA regulations); 
Young II, 525 F. App’x at 183 (holding that the “No Trans Fat” content claim was permitted by FDA 
regulations). 
 60 See Reid v. Johnson & Johnson (Reid II), 780 F.3d 952, 963 (9th Cir. 2015) (holding that the 
statement “No Trans Fat” on Benecol was not authorized); Young v. Johnson & Johnson (Young II), 
525 F. App’x 179, 183 (3d Cir. 2013) (holding that the statement “No Trans Fat” on Benecol was 
authorized). 
 61 See Young II, 525 F. App’x at 183. The court also held that the statement “No Trans Fatty Ac-
ids,” also on the label of Benecol, was a permitted nutrient content claim. See id. at 180, 183. 
 62 See id. at 182. The plaintiff argued that the statement “No Trans Fat” was misleading for the 
product as a whole, not on a per-serving basis. See id. 
 63 See id. (reasoning that nutrient content claims should match nutrient information based on the 
per-serving amount provided in the Nutrition Facts panel). The plaintiff in Young argued that the trans 
fat nutrient content claims were false and misleading because such statements were not expressly 
authorized for the product as a whole. See id. Young compared the trans fat nutrient content claims to 
the trans fat per serving statements that are expressly authorized in the Nutrition Facts panel. See id. 
 64 See id. (stating that 21 C.F.R. § 101.9(f)(1) (2013) explicitly states that 0.5 grams of trans fat 
per serving is insignificant). 
 65 See id. at 182–83 (referring to 21 C.F.R. § 101.62(b)–(c) (2013)). 
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nutrient content claims, which stated that in order to prevent consumer confu-
sion, a food product shall be considered “free” of a nutrient based on the 
amount of that nutrient per serving.66 Because the court concluded that the 
regulations authorize nutrient content claims based on the level of that nutrient 
in each serving, the court held that the claim “No Trans Fat” was not mislead-
ing and therefore was authorized by FDA regulations.67 In its opinion, the 
Third Circuit cited the Southern District of California’s 2012 decision Reid v. 
Johnson & Johnson (“Reid I”) and the Ninth Circuit’s 2012 unreported deci-
sion in Carrea v. Dreyer’s Grand Ice Cream, Inc. as support for its holding.68 
In 2015, in Reid v. Johnson & Johnson (“Reid II”), the U.S. Court of Ap-
peals for the Ninth Circuit reversed the district court’s finding that the plain-
tiff’s claims regarding false labeling of “No Trans Fat” were preempted.69 In 
holding that the statement “No Trans Fat” was not authorized by FDA regula-
tions, the Ninth Circuit’s holding was opposite to the Third Circuit’s in Young 
II, creating a circuit split.70 The Ninth Circuit in Reid II held that the statement 
“No Trans Fat” was not a permitted expressed nutrient content claim under the 
nutrition labeling “General Principles” regulations.71 The statement “No Trans 
Fat” is an expressed nutrient content claim because it directly states the 
amount of trans fat in Benecol.72 The “General Principles” regulations only 
permit expressed nutrient content claims that are not “false or misleading.”73 
                                                                                                                           
 66 See id. at 183 (citing 58 Fed. Reg. 44,020, 44,025 (Aug. 18, 1993) (codified at 21 C.F.R. pts. 5 
& 101)). The court recognized that nutrient content claims based on per-serving size might not neces-
sarily be accurate on a per product basis. See id. 
 67 See id. Therefore, the plaintiff’s claims related to the statement “No Trans Fat” were preempt-
ed. See id. 
 68 See id. at 183 n.5 (citing the Carrea v. Dreyer’s Grand Ice Cream, Inc., Reid v. Johnson & 
Johnson (“Reid I”), and Chacanaca v. Quaker Oats Co. decisions as support). 
 69 See Reid II, 780 F.3d at 963. 
 70 Compare id. (finding that including the statement “No Trans Fat” outside the Nutrition Facts 
label was misleading and not preempted), with Young II, 525 F. App’x at 183 (ruling that including 
the statement “No Trans Fat” outside the Nutrition Facts Label was consistent with FDA regulations). 
The Reid II decision also conflicted with the Ninth Circuit’s unreported decision in Carrea v. Drey-
er’s Grand Ice Cream, Inc. Compare Reid II, 780 F.3d at 963 (finding that including the statement 
“No Trans Fat” outside the Nutrition Facts label was misleading), with Carrea v. Dreyer’s Grand Ice 
Cream, Inc., 475 F. App’x 113, 115 (9th Cir. 2012) (dismissing plaintiff’s allegations that statements 
outside of the Nutrition Facts label that Drumsticks have “0g Trans Fat” were misleading). 
 71 See Reid II, 780 F.3d at 962 (referencing 21 C.F.R. § 101.13(i) (2014)). The court reasoned that 
if the statement “No Trans Fats” is false or misleading, then it is not an authorized expressed nutrient 
content claim. See id. 
 72 See id. (referencing 21 C.F.R. § 101.13(b)(1)–(2)). 
 73 See id. (referencing 21 C.F.R. § 101.13(i)(3)). FDA regulations permit express nutrient content 
claims if they are “not false or misleading in any respect.” 21 C.F.R. § 101.13(i)(3) (2015). 
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The court held that the statement “No Trans Fat” on Benecol’s label was mis-
leading and therefore was not permitted.74 
The Ninth Circuit determined that Benecol’s trans fat nutrient content 
claim was misleading by examining FDA warning letters and by analyzing the 
purpose of the FDA’s “Specific Requirements for Nutrient Content Claims” 
regulations for total fat and saturated fat.75 In two FDA warning letters, the 
FDA indicated that the statement “No Trans Fat” was an unauthorized nutrient 
content claim.76 The court determined that the FDA explicitly authorized “No 
Fat” and “No Saturated Fat” as nutrient content claims when the product con-
tains less than 0.5 grams because such claims are authorized under the “Specif-
ic Requirements for Nutrient Content Claims” regulations, even though those 
claims are not authorized under the “General Principles” regulations.77 The 
FDA chose not to authorize a trans fat nutrient content claim because of insuf-
ficient scientific information on the appropriate daily consumption value of 
trans fat.78 Thus, the court concluded that “No Fat” and “No Saturated Fat” 
claims were not authorized under the “General Principles” regulations because 
they were misleading.79 Accordingly, if “No Fat” and “No Saturated Fat” were 
misleading when the product contained small amounts of that nutrient per serv-
ing, the court concluded that “No Trans Fat” was also misleading when the 
product contained a small amount of that nutrient per serving.80 
                                                                                                                           
 74 See Reid II, 780 F.3d at 962 (reasoning that the statement “No Trans Fat” on the product’s label 
misleads the consumer to think there is none of that nutrient when in actuality there is between 0 and 
0.5 grams of trans fat per serving). 
 75 See id. at 962–93. The FDA issues warning letters as a means of informal enforcement action. 
21 C.F.R. § 100.2 (2015). Warning letters are a common type of enforcement measure. See 1 WAYNE 
L. PINES, FDA ADVERTISING AND PROMOTION MANUAL ¶ 910 (2015), 2004 WL 5032786. “Specific 
Requirements for Nutrient Content Claims” for total fat and saturated fat is contained in 21 C.F.R. 
§ 101.62. See 21 C.F.R. § 101.62 (2015). 
 76 See Reid II, 780 F.3d at 962 (stating that the court will “defer to the FDA’s interpretation of its 
own rules”). 
 77 See id. at 962–63 (referring to 21 C.F.R. §§ 101.13(i)(3) and 101.62(b)–(c)). The court ex-
plained that if the statements “No Fat” or “No Saturated Fat” were permitted under the “General Prin-
ciples” regulations, then the “Specific Requirements for Nutrient Content Claims” regulations for fat 
and total fat would be superfluous. See id. at 963. 
 78 See id. at 963 (referencing 68 Fed. Reg. 41,434, 41,464–65 (July 11, 2003) (codified at 21 
C.F.R. pt. 101), which states that because not enough scientific information exists to support a daily 
reference value for trans fat, the FDA declined defining a trans fat nutrient content claim). 
 79 See id. (reasoning that the statement “No Fat” or “No Saturated Fat” is misleading if the prod-
uct contains small amounts of fat or saturated fat, respectively, per serving). 
 80 See id. (reasoning that per 21 C.F.R. § 101.13(i)(3), “No Trans Fat,” “No Saturated Fat,” and 
“No Fat” should be treated the same when determining if the statements are false or misleading). 
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III. TRANS FAT NUTRIENT CONTENT CLAIM REGULATIONS  
ARE A STICKY MESS 
In 2015, in Reid v. Johnson & Johnson (“Reid II”), the U.S. Court of Ap-
peals for the Ninth Circuit reached its conclusion that the FDA had not author-
ized the trans fat nutrient content claim at issue, despite the U.S. Court of Ap-
peals for the Third Circuit reaching the opposite conclusion for the same prod-
uct in 2013 in Young v. Johnson & Johnson (“Young II”).81 Inconsistent judicial 
interpretation regarding the claims “No Trans Fat” and “0g Trans Fat” on 
products that have small amounts of trans fat per serving demonstrates the in-
adequacy of the trans fat regulations that have stemmed from the NLEA.82 In 
the area of trans fat nutrient content claims, the FDA is not fulfilling the 
NLEA’s objective of providing uniform food labeling standards, as evidenced 
by varying outcomes in two cases within different circuits that discuss the 
same nutrient content claim for the same product.83 The FDA should revisit its 
regulations pertaining to trans fat nutrient content claims to provide courts with 
the means to consistently interpret the permissibility of these claims under the 
FDA and to avoid misleading consumers.84  
The U.S. Court of Appeals for the Third Circuit, the U.S. Court of Ap-
peals for the Ninth Circuit, and district courts within the Ninth Circuit have 
                                                                                                                           
 81 Compare Reid v. Johnson & Johnson (Reid II), 780 F.3d 952, 963 (9th Cir. 2015) (holding that 
the nutrient content claim “No Trans Fat” was not authorized by the FDA, with Young v. Johnson & 
Johnson (Young II), 525 F. App’x 179, 183 (3d Cir. 2013) (holding that the nutrient content claim “No 
Trans Fat” was permitted). 
 82 See Nutrition Labeling and Education Act of 1990, Pub. L. No. 101-535, 104 Stat. 2353 (codi-
fied as amended in scattered sections of 21 U.S.C.); Hilary G. Buttrick & Courtney Droms Hatch, 
Pomegranate Juice Can Do That? Navigating the Jurisdictional Landscape of Food Health Claim 
Regulation in a Post-POM Wonderful World, 49 IND. L. REV. 267, 288 (2016) (recognizing that de-
termining whether a plaintiff’s claim is preempted by the NLEA can be difficult when FDA regula-
tions are relevant but do not explicitly address the claim); Winters, supra note 2, at 815 (arguing for 
the repeal of the NLEA’s nutrient content claim provisions); Sylvia Zarski, Comment, Can You Judge 
Your Food by Looking at Its Cover? How Courts’ Application of Federal Preemption Allows Mislead-
ing Food Labeling to Slip Through the Regulatory Cracks, 64 DEPAUL L. REV. 1119, 1137 (2015) 
(stating that the Ninth Circuit in Carrea v. Dreyer’s Grand Ice Cream, Inc. should not have held the 
claim “0g trans fat” to be preempted). 
 83 See Winters, supra note 2, at 859 (arguing that the FDA has failed to achieve uniform food 
labeling standards); supra notes 61–80 and accompanying text (discussing two different outcomes 
regarding the permissibility of trans fat nutrient content claims for the same product). Congress passed 
the NLEA with the goal of establishing national uniform standards in food labeling. See H.R. REP. 
NO. 101-538, at 7 (1990), reprinted in 1990 U.S.C.C.A.N. 3336, 3339. 
 84 See Jennifer L. Pomeranz, A Comprehensive Strategy to Overhaul FDA Authority for Mislead-
ing Food Labels, 39 AM. J.L. & MED. 617, 638–41 (2013) (proposing that the FDA be given the au-
thority to require “preauthorization” for nutrient content claims to reduce the amount of misleading 
claims); Winters, supra note 2, at 861 (arguing for the repeal of the NLEA’s nutrient content claim 
provisions); Zarski, supra note 82, at 1137 (arguing that courts have held that consumers’ claims are 
preempted when their claims are based on misleading statements on food labels). 
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struggled to analyze the permissibility of such claims.85 The Ninth Circuit, in 
determining the permissibility of the claims “No Trans Fat” and “0g Trans Fat” 
looked to the FDA by considering related FDA regulations, supplementary 
information published with a particular final rule, and warning letters.86 In an 
unreported 2012 opinion, Carrea v. Dreyer’s Grand Ice Cream, Inc., the Ninth 
Circuit reasoned that the claim “0g Trans Fat” was permitted based on a par-
ticular final rule’s supplementary information discussing reference claims.87 
The courts in Reid II and Young II interpreted differently whether the claim 
“No Trans Fat” on the same food product was “false or misleading” under FDA 
regulations.88 The Ninth Circuit in Reid II came to its conclusion by examining 
FDA warning letters that specifically stated that the claim “No Trans Fat” was 
not permitted and by analyzing the purpose of the “Specific Requirements for 
Nutrient Content Claims” regulations for total fat and saturated fat.89 In contrast, 
the Third Circuit in Young II reasoned that the claim at issue was permitted by 
considering related FDA regulations and by considering a particular final rule’s 
supplementary information stating that food products are considered “free” of a 
nutrient based on the amount of that nutrient per serving.90  
                                                                                                                           
 85 See Reid II, 780 F.3d at 962–93 (reversing the district court’s holding that the plaintiff’s claim 
was preempted by examining different authority than the district court); Young II, 525 F. App’x at 182 
(holding that the nutrient content claim “No Trans Fat” was permitted, even though the plaintiff ar-
gued that FDA regulations do not “expressly permit” such a claim); Guttmann v. Nissin Foods 
(U.S.A.) Co., Inc., No. 3:15-cv-00567, 2015 WL 4309427, at *3 (N.D. Cal. July 15, 2015) (citing 
Chacanaca v. Quaker Oats Co., 752 F. Supp. 2d 1111 (N.D. Cal. 2010)) (stating that, in 2010, in Cha-
canaca v. Quaker Oats Co., the judge applied a principle from the FDA’s discussion of relative claims 
to nutrient content claims); Reid v. Johnson & Johnson (Reid I), No. 3:11-cv-01310, 2012 WL 
4108114, at *10 (S.D. Cal. Sept. 18, 2012) (relying on the Ninth Circuit’s reasoning in Carrea), aff’d 
in part, rev’d in part, 780 F.3d 952; see also Carrea v. Dreyer’s Grand Ice Cream, Inc., 475 F. App’x 
113, 115 (9th Cir. 2012) (holding that the content claim “0g trans fat” is permitted by FDA regula-
tions); Winters, supra note 2, at 850 (stating that the court’s reasoning in Chacanaca was “intensive, 
time-consuming, and disputable”). 
 86 See Reid II, 780 F.3d at 962–93 (examining the purpose of other regulations and warning let-
ters); Carrea, 475 F. App’x at 115 (considering supplementary information to the final rule in 58 Fed. 
Reg. 44,020 (Aug. 18, 1993) (codified at 21 C.F.R. pts. 5 & 101)); see also Bowles v. Seminole Rock 
& Sand Co., 325 U.S. 410, 414 (1945) (reasoning that the administrative interpretation of a regulation 
is controlling “unless it is plainly erroneous or inconsistent with the regulation”). FDA warning letters 
are informal communications that do not necessarily represent the FDA’s view. See generally Paige S. 
Goodwin & Kevin T. Jacobs, A Primer on the Admissibility of FDA Warning Letters, 80 DEF. COUNS. 
J. 136 (2013) (discussing the admissibility of FDA warning letters in court). 
 87 See Carrea, 475 F. App’x at 115 (referring to 58 Fed. Reg. at 44,024). 
 88 Compare Reid II, 780 F.3d at 962 (holding that the claim “No Trans Fat” was not authorized), 
with Young II, 525 F. App’x at 182 (holding that the claim “No Trans Fat” was authorized). 
 89 See Reid II, 780 F.3d at 962–93. 
 90 See id. (referring to FDA warning letters and the purpose of 21 C.F.R. § 101.62 (2014)); Young 
II, 525 F. App’x at 183 (referring to 21 C.F.R. § 101.9(f)(1) (2013), 21 C.F.R. § 101.62(b)–(c) (2013), 
and 58 Fed. Reg. at 44,025). 
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To resolve the issue of inconsistent interpretation by courts, the FDA 
should address differences in the wording of such trans fat claims.91 Along 
with interpreting without uniformity if the claims “0g Trans Fat” and “No 
Trans Fat” are permitted by the FDA, district courts within the Ninth Circuit 
have disagreed on whether these claims are exact substitutes for each other.92 
The district court in Reid held that these claims should be treated the same.93 
Another district court, however, held that the claim “0 grams trans fat” re-
quired a different analysis than the claim “No Trans Fat.”94 
The FDA should also regulate trans fat nutrient content claims in a way 
that consumers will best understand.95 As reflected in the amount of litigation 
on trans fat nutrient content claims, consumers do not understand such nutrient 
content claims’ meaning and are being misled.96 The FDA must conform to its 
                                                                                                                           
 91 See 1 JAMES T. O’REILLY & KATHARINE A. VAN TASSEL, FOOD AND DRUG ADMIN. § 10:49, 
Westlaw (database updated Dec. 2015) (concluding that statements on food labels in which the word-
ing exactly matches statements defined in the regulations are “clearly” permitted nutrient content 
claims); BRUCE SILVERGLADE & ILENE RINGEL HELLER, CTR. FOR SCI. IN THE PUB. INTEREST, FOOD 
LABELING CHAOS: THE CASE FOR REFORM (2010), https://www.cspinet.org/new/pdf/food_labeling_
chaos_report.pdf [https://perma.cc/U82F-Y6AP] (advocating that the FDA should expand their regu-
lations so that courts no longer have to interpret the current regulations’ meanings); see, e.g., 21 
C.F.R. § 101.62(b) (2015) (stating what specific terms are permitted for total fat claims); id. 
§ 101.62(c) (stating what specific terms are permitted for saturated fat claims); id. § 101.62(d) (stating 
what specific terms are permitted for cholesterol claims). 
 92 Compare Reid I, 2012 WL 4108114, at *10 (indicating that “0g Trans Fat” and “No Trans Fat” 
have the same meaning), with Walker v. B&G Foods, Inc., No. 3:15-cv-03772, 2016 WL 463253, at 
*4 (N.D. Cal. Feb. 8, 2016) (suggesting that these statements may not be interchangeable), and 
Guttmann, 2015 WL 4309427, at *3 (stating that these statements require different analyses). 
 93 See Reid I, 2012 WL 4108114, at *10 (stating that distinguishing between the statements “0g 
Trans Fat” and “No Trans Fat” was “unreasonable”). 
 94 See Walker, 2016 WL 463253, at *4 (stating that while the FDA has provided guidance on the 
claim “No Trans Fat,” it has not commented on the claim “0g Trans Fat”); Guttmann, 2015 WL 
4309427, at *3 (stating that Reid II does not apply to the preemption analysis of the claim “0g Trans 
Fat” because the warning letters relied on by Reid II did not address the claim “0g Trans Fat” but 
instead “No Trans Fat). 
 95 See Winters, supra note 2, at 861 (noting that nutrient content claims have failed to provide 
“transparency and accuracy” to consumers); see also Zarski, supra note 82, at 1150 (stating that Car-
rea is one example of an instance in which a court has interpreted the FDA’s preemption provision too 
broadly, resulting in preventing consumers from challenging misleading statements). But see Zarski, 
supra note 82, at 1150 (noting that some of the information that the FDA allows or necessitates on 
food labels has the ability to mislead consumers). 
 96 See Pomeranz, supra note 84, at 621–22 (pointing out that consumers are confused by the 
meaning of nutrient content claims on food labels and stating that “[m]isleading and deceptive claims 
are expressly permitted or tactically ignored” by the FDA); see, e.g., Reid II, 780 F.3d at 962–63 (ana-
lyzing whether the statement “No Trans Fat” was misleading); Young II, 525 F. App’x at 182–83 
(same); Carrea, 475 F. App’x at 115 (confirming the lower court’s ruling that the claim “0g Trans 
Fat” was not misleading); Walker, 2016 WL 463253, at *3–4 (analyzing whether the claim “0g Trans 
Fat” was misleading); Guttmann, 2015 WL 4309427, at *2–3 (analyzing whether the nutrient content 
claim “0g Trans Fat” was misleading and therefore not permitted); Peviani v. Hostess Brands, Inc., 
750 F. Supp. 2d 1111, 1119–20 (C.D. Cal. 2010) (analyzing whether the FDA authorized the claim “0 
Grams of Trans Fat”); Red v. Kroger Co., No. 2:10-cv-01025, 2010 WL 4262037, at *4–5 (C.D. Cal. 
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mandate under the First Amendment to facilitate accurate speech that is not 
misleading to consumers.97 
CONCLUSION 
The Ninth Circuit’s holding in Reid II demonstrates the need for the FDA 
to provide clear regulations on trans fat nutrient content claims. Reid held that 
the FDA did not authorize the statement “No Trans Fat” based on FDA warn-
ing letters stating that this claim was not permissible. In Young II, however, the 
Third Circuit held that the same statement on the same product was authorized 
by the FDA. In order to ensure uniform application of FDA regulations, the 
FDA needs to revisit rules on trans fat nutrient content claims. Revising such 
regulations will assist the FDA in achieving the NLEA’s goal of providing uni-
form food labeling requirements and will help ensure that manufacturers do 
not mislead consumers. 
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Sept. 2, 2010) (analyzing whether the claim “0g Trans Fat” was misleading). For example, the plain-
tiff in Reid v. Johnson & Johnson interpreted “No Trans Fat” to mean that the product did not contain 
any trans fats throughout the product. See Reid II, 780 F.3d at 962. Similarly, the plaintiffs in Cha-
canaca interpreted “0 grams trans fat” to mean the product did not contain any trans fats. See 752 
F. Supp. 2d at 1119. Likewise, the plaintiff in Carrea understood “0g Trans Fat” to mean that the 
product did not contain any trans fats. See 2011 WL 159380, at *1. 
 97 See U.S. CONST. amend. I; Food Labeling: Trans Fatty Acids in Nutrition Labeling, Nutrient 
Content Claims, and Health Claims, 68 Fed. Reg. 41,434, 41,437, 41,465 (July 11, 2003) (codified at 
21 C.F.R. pt. 101) (acknowledging, in the supplementary information for the rule requiring the disclo-
sure of trans fats in the Nutrition Facts panel, that the FDA has the responsibility to ensure “truthful 
and nonmisleading” speech on the labels of food products). 
